Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
A small randomized trial of vitamin D plus vaginal probiotics increased clinical pregnancy and showed a numerically higher live-birth outcomes, though precision was limited.
Source: Higher-certainty interventional evidence from randomized controlled trials. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis not reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level
Source: Article title.
When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level
Systematic review · Frontiers in Endocrinology · 2026
Original publication title
Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level
Copyright © 2026 Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasman.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
The aim of this study was to synthesize evidence on interventions that restore or improve fertility in women aged 30 to 42 years, grouped by etiology.
Source: ObjectiveAbstract: Importance
Female infertility affects approximately one in six couples worldwide and disproportionately impacts women aged 30 to 42 years, yet evidence on which interventions improve clinically meaningful outcomes (live birth and safety) is heterogeneous.
Source: ImportanceAbstract: Evidence review
We conducted a PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-compliant systematic review (PROSPERO CRD420251109428). PubMed and Scopus were searched for English/Spanish studies (1 January 2020 to 31 July 2025). Eligible designs were randomized trials and non-randomized interventional and observational studies. We aligned outcomes to the infertility core outcome set, prioritizing live birth per woman, then ongoing/clinical pregnancy and prespecified safety endpoints. Risk of bias used RoB 2 [randomized controlled trials (RCTs)], ROBINS-I (non-randomized), and JBI (observational). When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.
Source: Evidence reviewAbstract: Conclusions and relevance
For women aged 30 to 42 years, established hormonal and ART strategies improve pregnancy outcomes; however, certainty for live birth and safety remains limited. Clinical care should prioritize standard therapies and shared decision-making, acknowledging evidence gaps. Future trials must center on live birth, adopt standardized core outcomes, and consistently report maternal: neonatal safety.
Source: Conclusions and relevanceAbstract: Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD420251109428.
Source: Systematic review registrationAbstract: Findings
A total of 21 studies met inclusion criteria for synthesis, and two additional randomized protocols were summarized narratively (23 records tracked overall). Interventions spanned hormonal therapies, assisted reproductive technologies (ART) strategies, surgical procedures, lifestyle and psychosocial programs, and investigational adjuncts. Across etiologies, several interventions were associated with improved pregnancy-related outcomes: such as myo-inositol, clomiphene with sildenafil, selected luteal support regimens, structured stress management, and specific ART strategies: whereas live-birth effects were supported by only moderate-certainty evidence, limited by small samples, heterogeneity, and indirectness.
Diagnostic and prognostic approaches (e.g., serum progesterone profiling, BAP-EB receptivity assay, and endometrial T-bet/GATA3 ratio) showed predictive value but no therapeutic effect. Safety reporting was limited; few studies reported ovarian hyperstimulation syndrome, multiple gestation, or neonatal outcomes, and patient-reported outcomes were seldom assessed.
Source: FindingsAuthors’ abstract
Importance
Female infertility affects approximately one in six couples worldwide and disproportionately impacts women aged 30 to 42 years, yet evidence on which interventions improve clinically meaningful outcomes (live birth and safety) is heterogeneous.
Objective
The aim of this study was to synthesize evidence on interventions that restore or improve fertility in women aged 30 to 42 years, grouped by etiology.
Evidence review
We conducted a PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-compliant systematic review (PROSPERO CRD420251109428). PubMed and Scopus were searched for English/Spanish studies (1 January 2020 to 31 July 2025). Eligible designs were randomized trials and non-randomized interventional and observational studies. We aligned outcomes to the infertility core outcome set, prioritizing live birth per woman, then ongoing/clinical pregnancy and prespecified safety endpoints. Risk of bias used RoB 2 [randomized controlled trials (RCTs)], ROBINS-I (non-randomized), and JBI (observational). When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.
Findings
A total of 21 studies met inclusion criteria for synthesis, and two additional randomized protocols were summarized narratively (23 records tracked overall). Interventions spanned hormonal therapies, assisted reproductive technologies (ART) strategies, surgical procedures, lifestyle and psychosocial programs, and investigational adjuncts. Across etiologies, several interventions were associated with improved pregnancy-related outcomes: such as myo-inositol, clomiphene with sildenafil, selected luteal support regimens, structured stress management, and specific ART strategies: whereas live-birth effects were supported by only moderate-certainty evidence, limited by small samples, heterogeneity, and indirectness.
Diagnostic and prognostic approaches (e.g., serum progesterone profiling, BAP-EB receptivity assay, and endometrial T-bet/GATA3 ratio) showed predictive value but no therapeutic effect. Safety reporting was limited; few studies reported ovarian hyperstimulation syndrome, multiple gestation, or neonatal outcomes, and patient-reported outcomes were seldom assessed.
Conclusions and relevance
For women aged 30 to 42 years, established hormonal and ART strategies improve pregnancy outcomes; however, certainty for live birth and safety remains limited. Clinical care should prioritize standard therapies and shared decision-making, acknowledging evidence gaps. Future trials must center on live birth, adopt standardized core outcomes, and consistently report maternal: neonatal safety.
Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD420251109428.
Publication and source details
Original title: Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level
Maria Jimena Barroso Alverde; Sion Yu; Daniel Pascal Pontón; Denise Niza Benardete Harari; José Elias Tesone Lasman
Frontiers in Endocrinology · 2026
* Correspondence: Maria Jimena Barroso Alverde, jimenabarroso1@gmail.comCopyright © 2026 Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasman.2026Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasmanhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:20:21.154534+00:00
DOI: 10.3389/fendo.2026.1741198 · PMC13286824